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Molecular mechanisms of the non-
coenzyme action of thiamin in 
brain: biochemical, structural and 
pathway analysis
Garik Mkrtchyan1, Vasily Aleshin1, Yulia Parkhomenko2, Thilo Kaehne3, Martino Luigi 
Di Salvo4, Alessia Parroni4, Roberto Contestabile4, Andrey Vovk5, Lucien Bettendorff6 & 
Victoria Bunik1,7
Thiamin (vitamin B1) is a pharmacological agent boosting central metabolism through the action of 
the coenzyme thiamin diphosphate (ThDP). However, positive effects, including improved cognition, 
of high thiamin doses in neurodegeneration may be observed without increased ThDP or ThDP-
dependent enzymes in brain. Here, we determine protein partners and metabolic pathways where 
thiamin acts beyond its coenzyme role. Malate dehydrogenase, glutamate dehydrogenase and 
pyridoxal kinase were identified as abundant proteins binding to thiamin- or thiazolium-modified 
sorbents. Kinetic studies, supported by structural analysis, revealed allosteric regulation of these 
proteins by thiamin and/or its derivatives. Thiamin triphosphate and adenylated thiamin triphosphate 
activate glutamate dehydrogenase. Thiamin and ThDP regulate malate dehydrogenase isoforms and 
pyridoxal kinase. Thiamin regulation of enzymes related to malate-aspartate shuttle may impact 
on malate/citrate exchange, responsible for exporting acetyl residues from mitochondria. Indeed, 
bioinformatic analyses found an association between thiamin- and thiazolium-binding proteins 
and the term acetylation. Our interdisciplinary study shows that thiamin is not only a coenzyme 
for acetyl-CoA production, but also an allosteric regulator of acetyl-CoA metabolism including 
regulatory acetylation of proteins and acetylcholine biosynthesis. Moreover, thiamin action in 
neurodegeneration may also involve neurodegeneration-related 14-3-3, DJ-1 and β-amyloid precursor 
proteins identified among the thiamin- and/or thiazolium-binding proteins.
The knowledge of the molecular mechanisms underlying the pharmacological effects of drugs is indis-
pensable to improve their safety and efficiency. The identification of molecular targets of pharmaco-
logically active compounds is an important step to understand such molecular mechanisms, and is 
greatly advanced by modern development of high-throughput analytical and bioinformatics approaches. 
Thiamin (also known as vitamin B1) is widely used in neuropharmacology. In particular, its administra-
tion causes a transient improvement in cognitive function of some patients affected by neurodegenerative 
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diseases, including Alzheimer’s disease (AD) and Parkinson’s disease (PD)1–5. The importance of thiamin 
administration in elderly is supported by the fact that the levels of thiamin and its coenzyme form, 
thiamin diphosphate (ThDP), are decreased with age6. In patients with neurodegenerative diseases, such 
as AD and fronto-temporal dementia, significantly less ThDP than in the age-matched control group 
was determined in post-mortem cortex samples7,8. Several features of thiamin pharmacology are worth 
noting. First, rather high doses of this vitamin (e.g. app. 14- and 90-fold excesses over the recommended 
daily dose in a Vitamin B-Komplex of Ratiopharm GmbH, Germany, and Neuromultivit of Lannacher 
Heilmittel GmbH, Austria, respectively) can be employed in medical practice, as they are not known 
to have adverse effects. Second, apart from the widely accepted ThDP action as a coenzyme of cen-
tral metabolism, thiamin has long been known to co-release with acetylcholine9–11 facilitating synaptic 
transmission12. Independent studies suggested the involvement of proteins of synaptosomal plasmatic 
membrane hydrolyzing the non-coenzyme derivative thiamin triphosphate (ThTP)13–17 and phospho-
rylating synaptic proteins with ThTP as a phosphate donor18. Yet, the identification of either molecular 
targets of this non-coenzyme action of thiamin, or proteins metabolizing the non-coenzyme derivatives 
of thiamin, is far from completion. A new cell membrane ThDP transporter19 and poly(ADP-ribose) 
polymerase-1 (PARP-1) regulated by adenylated ThTP20, have recently been added to the five known 
mammalian proteins of thiamin metabolism, such as the two thiamin transporters of cell membrane, 
ThDP transporter of mitochondria, soluble thiamin triphosphatase and thiamin diphosphokinase. 
However, the enzymes producing adenylated thiamin di- or triphosphates21 and the other mammalian 
targets of thiamin non-coenzyme forms were neither purified to homogeneity, nor identified at molecu-
lar level12. This greatly hinders the understanding of the molecular mechanisms of non-coenzyme action 
of thiamin and its derivatives in vivo. Also ThDP has non-coenzyme functions beyond its coenzyme role. 
For instance, it affects protein translation, either as riboswitch in thiamin-synthesizing species (plants 
and bacteria), or through regulation of p53 binding to DNA in mammals22. Insofar, natural thiamin 
derivatives may be pharmacologically significant not only due to the well-known coenzyme role of ThDP 
in central metabolism. Another important aspect is that pharmacological compounds often possess het-
erocycles which are structurally similar to those present in thiamin and derivatives, and may therefore 
act by targeting thiamin-dependent pathways23. In particular, drugs which reduce hyperphosphorylated 
tau-protein in AD mouse models24 possess structural similarity to thiamin and may therefore mimic or 
interfere with the pathways of the thiamin non-coenzyme action in synaptic transmission. The existence 
of such pathways, in addition to the known metabolic role of ThDP, could explain the absence of a 
robust correlation between positive effects of thiamin in patients with neurodegenerative diseases and 
activities of ThDP-dependent enzymes and ThDP levels in the brain of these patients13,25. Our work 
aims at the molecular identification of proteins and pathways involved in the non-coenzyme action of 
thiamin compounds. To do so, we used a previously established protocol to obtain a fraction of brain 
synaptosomes enriched with thiamin binding and thiamin phosphates hydrolyzing proteins14,15,17,26. The 
fraction was subjected to affinity chromatography on thiamin- or 3-decyloxycarbonylmethyl-4-methyl-5
-(2-hydroxyethyl) thiazolium (DMHT)-modified sorbents. The latter sorbent includes a decyloxycar-
bonylmethyl moiety attached to 4-methyl-5-(2-hydroxyethyl)-thiazolium heterocycle. This could mimic 
membrane-directed hydrophobic interactions of the aminopyrimidine ring of thiamin, whereas the het-
erocycle is specific to thiamin, i.e. not known to occur in natural compounds other than thiamin in 
animals. In addition, the heterocycle of DMHT is structurally similar to the thiamin degradation prod-
uct 4-methyl-5-(2-hydroxyethyl)-thiazole, which has been identified after thiamin injection in differ-
ent mammalian tissues, including brain27. Because thiamin degradation was detected also in germ-free 
rats28, the process is obviously performed not only by intestinal microflora, but also by mammalian 
thiamin-degrading enzymes. The non-coenzyme role of thiamin, especially at high doses, may also 
depend on the role of thiamin degradation products. In good accordance with this suggestion, DMHT 
was earlier shown to affect neuromuscular junctions, apparently through its effects on associated currents 
of calcium and potassium ions29. The observation of the neurophysiological effects of DHMT in vivo30,31, 
however, was never extended to the identification of DMHT-binding proteins. In the present work, the 
enriched synaptosomal fractions collected upon elution from affinity chromatography were identified 
by tandem liquid chromatography–mass spectrometry (LC-MS/MS). The sets of proteins identified in 
the eluates from the thiamin- and DMHT-derivatized sorbents will hereinafter be mentioned as thia-
min and thiazolium proteome, respectively. These partial synaptosomal proteomes were also analyzed 
by bioinformatics approaches, taking into account published data. Along with identification of known 
thiamin-dependent proteins and their heterologous protein partners, the analyses revealed a significant 
similarity between the protein components of thiamin and thiazolium proteomes. On the other hand, 
the common features of the two proteomes were shown to differ from those characteristic of other 
partial brain proteomes, such as the one containing DJ-1-binding proteins32 and the proteome of fron-
tal cortex33. Non-random and common co-occurrences of the eluted proteins and protein clusters in 
thiamin and thiazolium proteomes favors specific interactions, both direct and protein-mediated, of our 
preparation of synaptosomal proteins with the thiamin and DMHT baits of the affinity sorbents used in 
this work. For the most abundant enzymes of both proteomes, the specificity was confirmed by kinetic 
studies, showing the effect of thiamin and its derivatives on the activity of these enzymes. Available 
structural data, together with kinetic analysis, were used to assess potential thiamin-binding sites in the 
enzyme 3D structures. As a result, targets of the thiamin non-coenzyme action in brain were shown 
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to include the enzymes involved in metabolic communication between cytoplasm and mitochondria 
through malate-aspartate shuttle. Our bioinformatics analyses of thiamin and thiazolium proteomes also 
identified other thiamin-dependent pathways, including signaling through 14-3-3 proteins and calcium 
ions, redox defense and signaling involving peroxiredoxins and DJ-1 (parkin-7). Moreover, in view of the 
thiamin action in neurodegenerative diseases, the identification in the thiazolium proteome of β -amyloid 
precursor proteins is of particular interest.
Materials and Methods
Materials. Biochemicals, substrates and co-factors were from Sigma-Aldrich (Taufkirchen, Germany) 
and of the highest quality available. Commercial preparation of the purified glutamate dehydrogenase 
(GDH) from bovine liver (≥ 35 units/mg protein) and malate dehydrogenase (MDH) from porcine 
heart mitochondria (600–1000 units/mg protein) were from Sigma-Aldrich (Taufkirchen, Germany). 
Mass-spectrometry chemicals were: acetonitrile, LC-MS grade from VWR/Prolabo (Dresden, Germany); 
formic acid, ammonia carbonate and trifluoricacetic acid were from Fluka (Germany); Trypsin-Gold 
from Promega (Germany); methanol, glacial acetic acid and methoxyamine hydrochloride from Sigma-
Aldrich (Taufkirchen, Germany); pyridine from Merck (Darmstadt, Germany). Cell culture media were 
from Gibco (Carlsbad, CA, USA). 3-decyloxycarbonylmethyl-4-methyl-5-(2-hydroxyethyl) thiazolium 
(DMHT) was obtained according to30. Thiamin triphosphate and its adenylated form were obtained as 
in21,34.
Ethics Statement. The animal experiments conducted in the present study conform to the Guide 
for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH 
Publication No. 85-23, revised 1996) and the EU Directives 86/609/EEC and 2010/63/EU. All animal 
experiments were approved by the institutional committees for animal care and use, such as Bioethics 
Committee of Moscow Lomonosov State University, Committee for animal care and use of the University 
of Liege and Committee for procuration, husbandry and usage of experimental animals of Palladin 
Institute of Biochemistry of NAS of Ukraine.
Isolation of delipidated brain synaptosomal proteins. All procedures were done at 4–8 °C. 
Animals were kept at 21 ± 2 °C on standard ration without additional vitamin supplementation and 
12/12 h light/dark cycle. 18–20 Wistar male rats of 200–250 g were killed by decapitation. Extracted 
brains (app. 1.5 g each) were cleaned from blood vessels on ice and homogenized in the ice-cold isolation 
buffer, i.e. 5 mM Tris-HCl buffer (tris(hydroxymethyl)aminomethane), pH 7.4, containing 0.32 M sucrose 
and 0.5 mM PMSF (phenylmethanesulfonylfluoride), using a Potter homogenizer with teflon pestle. Cell 
debris and nuclei were removed by a 10 min centrifugation at 1000 g. Crude synaptosomes including 
mitochondria were pelleted by centrifugation of the supernatant for 20 min at 15000 g. The pellet was 
suspended in 10 mL of the isolation buffer, followed by addition of 9 volumes of cold (− 20 °С) acetone. 
The mixture was homogenized in the Potter homogenizer, and the suspension was incubated under mod-
erate shaking for 10 min at 4 °С. The delipidated proteins were filtered on Buchner funnel, and washed on 
the glass filter with a double volume of ether. The protein pellet (so called “acetone powder”) was further 
dried at room temperature for 10–15 min and stored (up to several days) at − 20 °С until affinity chro-
matography. To solubilize the proteins for chromatography, the acetone powder was mixed with 10 mM 
Tris-HCl buffer, pH 7.4, at a ratio of 20 mL of buffer per 1 g of powder. The mixture was homogenized in 
the Potter homogenizer and incubated under shaking for 30 min at 4 °С. Insoluble material was removed 
by a 10 min centrifugation at 20000 g. The solubilized proteins were diluted two-fold with an equal vol-
ume of the Ringer-bicarbonate buffer, pH 7.4 (final concentrations of the components in mM, are: NaCl 
118, KH2PO4 2.34, KCl 4.6, MgSO4•7H2O 1.19, CaCl2 2.42, NaHCO3 24.9, glucose 10), and the solution 
was subjected to affinity chromatography.
Affinity sorbents. Thiamin- and thiazolium-binding proteins of brain synaptosomes were puri-
fied by affinity chromatography on sorbents carrying chemically bound thiamin or DMHT as bait. 
The baits were connected to diazotized sorbent-attached linker (7-(2,4-diaminophenyl)heptanoic acid 
hydrazide) through C2 atom of the thiazolium ring. The baits and the linkers were incorporated into 
the CNBr-activated Sepharose according to the described procedure35. Briefly, coupling of the linker to 
CNBr-activated Sepharose 4В was carried out in acetic acid for 8 hours at 4 °С. The resulting sorbent 
with the attached linker was washed with 50% dioxane and water, followed by diazotation through a 
7 min incubation with 0.1 M sodium nitrite upon shacking at 4 °С. The diazotized sorbent was suspended 
in sodium borate buffer containing thiamin or DMHT, and рН of the suspension was adjusted to 8.6. 
Coupling of the baits to sorbent was performed for 4 hours at 4 °С, resulting in red products. The sor-
bents carrying the baits were washed with cold water and stored in aqueous suspension with 0.02% 
sodium azide. The bifunctional linker was used to enlarge conformational spectrum of the incorpo-
rated baits. Conformations of the baits in the two monosubstituted products could be different due to 
non-equivalence of their proximity to the hydrophobic linker. Modification of both diazonium groups 
of the diazotized linker was not supposed to occur to significant extent due to steric hindrance and 
relatively short (4 hours) modification time. This assumption agreed with no principal difference in the 
purification of the thiamin phosphate hydrolase activity using the sorbents whose linkers carried either 
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one or two diazonium groups. The modification was terminated by washing out the reactants from the 
sorbent. The diazonium group which would not react with the bait within the modification time was 
deactivated by hydrolysis to the corresponding phenol.
Affinity chromatography. The procedure was done according to an earlier protocol, which was elab-
orated to collect the fraction of synaptosomal proteins binding S35-thiamin and hydrolyzing thiamin 
phosphates, such as ThTP, ThDP and ThMP26. Solubilized proteins of the acetone-delipidated fraction 
of the crude rat brain synaptosomes were applied to a column with affinity sorbent (1.2 × 7 cm) equili-
brated with Ringer-bicarbonate buffer, pH 7.4, at a rate of 2–3 mL per hour. Non-bound proteins were 
washed out until absorbance of the eluate at 280 nm approached background level. Bound proteins were 
eluted step-wise, at first with a 10 mM Tris-HCl buffer, pH 7.4, then with 1 M NaCl and finally with 
the same buffer containing 2 M urea, at a rate of 18 mL per hour. Hydrolysis of commercially available 
ThDP (ThDPase) was used to follow the elution of thiamin binding/hydrolase activity towards thiamin 
phosphates from the affinity sorbents. The fractions with the ThDPase activity were pooled, subject to 
rapid desalting on Sephadex G25, and dialyzed overnight against 10 L of 10 mM Tris-HCl buffer, pH 7.4. 
After dialysis, the proteins were lyophilized and stored frozen at − 80 °С up to several months. During 
the period of biochemical analyses (a week), dissolved aliquots of lyophilized protein for experimental 
work were stored frozen at − 20 °С. Affinity sorbents were regenerated by a step-wise washing with 8M 
urea and distilled water, and stored in 0.02% sodium azide.
Proteome identification. Proteins in the eluates were separated by SDS (sodium dodecyl sulfate) 
electrophoresis and identified by mass-spectrometry (LC-MS/MS) after trypsin digestion as described 
previously36. In brief, the bands of interest were excised and in-gel digested in an adapted manner 
according to reference37. Gel pieces were washed 2 times by repeated addition and removing of 0.1 M 
NH4HCO3 and acetonitrile, respectively, followed by drying down in a vacuum centrifuge. The proteins 
were reduced by rehydrating the gel pieces in 10 mM dithiothreitol for 45 min at 56 °C and further car-
bamidomethylated by adding 55 mM iodineacetamide for 30 min at room temperature. Gel pieces were 
washed again 2 times, dried down, rehydrated by a freshly prepared digestion buffer containing 50 mM 
NH4HCO3 and 12.5 ng/μ L of trypsin gold (Promega), and incubated at 37 °C overnight. Generated tryp-
tic peptides were extracted from the gel by repeated addition of a sufficient volume of 25 mM NH4HCO3 
and acetonitrile, respectively. The extraction was forced by sonication. All extracts were pooled and 
dried down in a vacuum centrifuge. The peptides were redissolved in 5 μ l of 0.1% trifluoroacetic acid 
and purified on ZIP-TIP, C18-nanocolumns (Millipore, Billerica, USA). Peptides were eluted in 7 μ l of 
70% (v/v) acetonitrile and subsequently dried in a vacuum centrifuge. Dried samples were dissolved in 
10 μ l of 2% acetonitrile/0.1% trifluoroacetic acid and applied to an Ultimate 3000 Nano-HPLC (Dionex, 
Germany). Each sample was first trapped on a 1 mm PepMap-trapping column (Dionex, Germany) for 
10 min at 30 μ l/min of 2% acetonitrile/0.1% trifluoroacetic acid and subsequently subjected to a 75 μ m 
inner diameter, 5 cm PepMap C18-column (Dionex, Germany). Peptide separation was performed by an 
acetonitrile-gradient (2%–50% acetonitrile for 40 min; 50%–90% acetonitrile for 10 min) at 300 nl/min. 
The separation column outlet was online coupled to a nano-spray interface (Bruker, Germany) of an 
Esquire HCT ETDII-Iontrap mass spectrometer (Bruker, Germany). Mass spectra were acquired in pos-
itive MS mode, tuned for tryptic peptides. MS/MS-precursor selection was performed in an optimized 
automatic regime, with preference for double and triple charged ions. Every selected precursor was frag-
mented by collision induced dissociation (CID) and electron transfer dissociation (ETD), respectively. 
MS/MS spectra were processed by the Data Analysis and BioTools software from Bruker, Germany. 
Combined CID/ETD-derived fragment lists were analyzed by two independent in-built statistical analysis 
algorithms: MASCOT probability scoring (Matrix Science Ltd, London, UK) and ProteinExtractor scor-
ing (Bruker Daltonics, Bremen, Germany). Scores for peptide identification are given in Supplementary 
Table S1. The final table of the thiamin and thiazolium proteomes includes the best of repeated identi-
fications of each protein.
Bioinformatics approaches. Web-based bioinformatics resources DAVID (http://david.abcc.ncifcrf.
gov)38; STRING (http://string-db.org/)39 and PANTHER (http://www.pantherdb.org/)40; were used to 
analyze the proteomes. PROSITE (http://prosite.expasy.org/)41 was used to create patterns42 and search 
for their matches in other proteins. Multiple alignments were done using Jalview (http://www.jalview.
org/)43, CLUSTAL Omega44 and MUSCLE45. All manipulations with three dimensional (3D) structures 
were performed by PyMOL (http://www.pymol.org/)46.
Identification of the thiamin-binding patterns in proteins. In order to localize potential thiamin 
binding sites in the proteins bound to the thiamin- and DMHT-modified sorbents, protein structural 
elements binding thiamin and its thiazole ring were identified from the solved structures of human 
thiamin diphosphokinase (UNIPROT_ID: TPK1_HUMAN) in complex with ThDP (PDB ID: 3S4Y) 
and the thiamin-synthesizing bacterial enzyme ThiM (UNIPROT_ID: THIM_BACSU) in complex with 
4-methyl-5-(2-hydroxyethyl) thiazole (PDB ID: 1C3Q), respectively. A common structural element 
binding thiamin in human thiamin diphosphokinase and bacterial periplasmic thiamin/ThDP-binding 
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protein (UNIPROT_ID: THIB_ECOLI)47 was found by examining their solved structures with ThDP and 
thiamin, PDB ID: 3S4Y and PDB ID: 2QRY, respectively.
Multiple sequence alignments of the pattern-providing enzymes from different organisms were then 
performed by CLUSTAL Omega44 and MUSCLE45 to find possible variations in the pattern structures. 
The resulting patterns [QK]x(0,1)Dx(0,1)[TS]Dx(3)[ACMVITS][LVIMF] and [ILV][ST][ST][ST]N (thi-
amin diphosphokinase- and thiamin diphosphokinase/ThiB-based), Ax(9)[PA][AVILFM][MI]x(20,22)
[GA][TSNKAH] (ThiM-based), and the known motif common for the ThDP-dependent enzymes48, 
updated as G[DE][GA]x(24,30)NN according to the recent multiple sequence alignment49 were submit-
ted to PROSITE (http://prosite.expasy.org/)41. Sequences of malate dehydrogenases, glutamate dehydro-
genases and pyridoxal/pyridoxamine kinases found by the PROSITE scan against the thiamin-binding 
patterns were aligned to the orthologues with the resolved 3D structures, based on multiple sequence 
alignment of app. 70 proteins. The thiamin-binding patterns were visualized in the 3D structures of the 
proteins of interest using PyMOL (http://www.pymol.org/)46.
Enzymes and assays. During purification of the thiamin phosphate hydrolase(s) from the synapto-
somal protein fraction as described earlier26,50, routine assays of the eluate were done using the malachite 
green determination of phosphate51 released upon ThDP hydrolysis. Cytosolic fraction and extracts of 
brain mitochondria were used to assay brain enzymes, such as cytosolic and mitochondrial malate dehy-
drogenases and glutamate dehydrogenase. Brain homogenate fractionation and mitochondria sonication 
were done according to the published procedure36, with the mitochondrial pellet washed three times in 
order to ensure separation of the cytosolic enzymes. Wild-type human pyridoxal kinase (PdxK) was 
expressed and purified as previously published52, except for final dialysis that was carried out overnight 
against 50 mM sodium N,N-bis(2-hydrozyethyl)-2-aminoethanesulfonate (BES) buffer, pH 7.3. Varied 
conditions of the enzymatic assays are given in the figure legends. Assay of the enzyme fraction added 
to the medium omitting one substrate was used as a blank. The assays were mostly performed in the 
Ringer-bicarbonate buffer, pH 7.4, used for the protein binding to affinity sorbents. However, PdxK was 
inhibited by the ionic composition of this buffer, owing to which its activity was measured as described 
earlier53. Briefly, initial velocity studies for the conversion of pyridoxal to pyridoxal-5’-phosphate were 
followed at 388 nm in 50 mM sodium BES buffer, pH 7.3. Inhibition by thiamin and ThDP was studied 
at quasi-saturating concentrations of both substrates (1.8 mM of MgATP and 0.6 mM of pyridoxal) and 
increasing concentrations of inhibitors, ranging from 1 to 30 mM. Experimental data were fitted to the 
hyperbolic Equation (1) in which Y is the fractional activity, [I] is the concentration of inhibitor and K iapp 
is the apparent inhibition constant:
Y I
I K
[ ]
[ ] 1iapp
=
+ ( )
Kinetic parameters and inhibition constants were determined by Lineweaver-Burk analysis and cor-
responding secondary plots as summarized in54.
Statistical analysis. Differences between the affected and control values were estimated by Student’s 
t-test. At least three replicates were used when assaying the enzyme activities.
Results
Affinity purification of synaptosomal thiamin and thiazolium proteomes. Parkhomenko et al. 
showed earlier that the proteins binding S35-thiamin and hydrolizing ThTP, ThDP, ThMP with the relative 
efficiencies 100%, 60% and 20%, correspondingly, are co-eluted from the affine sorbent modified with thi-
amin14,15,17,26. Our affinity purification was based on these studies. The procedure included a step-wise salt 
and urea elution from the affinity sorbents with thiamin or 3-decyloxycarbonylmethyl-4-methyl-5-(2-hy-
droxyethyl) thiazolium (DMHT) covalently bound to a spacer. Table 1 summarizes affinity purification 
of the acetone-delipidated fraction of synaptosomal proteins to obtain the thiamin-binding proteins con-
taining the thiamin phosphates hydrolase activity (ThDPase, Table  1). The total protein portion of the 
Bait
Brain 
FW, g
Mass of 
affinity 
sorbent, g
Protein 
applied, 
mg
Protein yield and specific activity (nmol 
phosphate/min per mg of protein) eluted
1 M NaCl 2 М urea
mg/% TDPase mg/% TDPase
Thiamin 25 0.8 110 1.5/1.4 200 1.1/1.3 3.2
DMHT 25 0.7 90 0.3/0.4 92 1.1/1.2 27
Table 1.  Affinity purification of the thiamin phosphate hydrolyzing activity (ThDPase) from the 
acetone-delipidated synaptosomal proteins of rat brain.
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acetone-delipidated fraction represented about 0.4% of the tissue fresh weight. Combined (i.e. fractions 
eluted with 1 M NaCl and 2 M urea) yield of protein from the affinity thiamin- and DMHT-modified 
sorbents was 2.7 and 1.6% of the protein applied to the two sorbents, respectively. SDS-electrophoresis 
of the pooled fractions containing the hydrolase activity towards thiamin phosphates in the eluates from 
the two sorbents is shown in Supplementary Fig. S1. As seen from Table 1 and Supplementary Fig. S1, 
1 M NaCl efficiently disrupted the protein interactions with thiamin-modified sorbent, whereas 2 M urea 
was a better eluent from the DMHT-modified sorbent, probably due to additional hydrophobic inter-
action with the decyl moiety of DMHT. MS identification of eluted proteins (Supplementary Table S1) 
showed that there was no clear distribution of proteins eluted from the same sorbent by NaCl and urea. 
That is, the same proteins could elute either with NaCl or urea from the thiamin- or DMHT-modified 
sorbents. Therefore, the combined proteome (i.e. eluted from each sorbent by both NaCl and urea) was 
further analyzed.
Overall analysis of the proteomes eluted from the thiamin- and DMHT-modified affinity sor-
bents. Specific binding of proteins to affinity sorbents may occur through (i) direct interaction with 
the bait and (ii) interaction of the bait with biologically relevant heterologous protein-protein complex, 
given that one protein of the complex specifically interacts with the bait. Table  2 shows that the pro-
teomes eluted from the two sorbents contained many proteins known to bind thiamin compounds and 
interaction partners of such proteins. Taking into account the total number of identified proteins (150 
and 57 in the thiazolium and thiamin proteomes, respectively, (Supplementary Table S1), the proteins 
known to bind thiamin and their immediate interaction partners (Table 2) accounted for 10–13% of the 
proteomes. In view of the fact that heterologous complexes may involve not only the known and direct 
partners of the thiamin-dependent proteins shown in Table  2, but also those unknown and indirect, 
this value corresponds to the lowest limit of specific interactions with the affinity sorbents. In addition 
to the interactions listed in Table  2, multiple indirect or unknown interactions with thiamin are sup-
ported by published data. In particular, the thiazolium proteome (Supplementary Table S1) includes 
the protein PHYIP_RAT, annotated as interacting with phytanoyl-CoA hydroxylase, the first enzyme 
of the ThDP-dependent pathway of phytanoyl-CoA degradation55. Furthermore, many proteins listed 
in Supplementary Table S1 were shown to co-immunoprecipitate with ThDP-dependent 2-oxoglutarate 
dehydrogenase (OGDH) in an independent study which by molecular biology approaches revealed the 
interaction of OGDH with fatty acid metabolism56. Thiazolium proteome also includes DJ-1 protein 
Protein ID Protein name
Proteome
Interaction partner SourceT DHMT
ODO1_RAT 2-oxoglutarate dehydrogenase, mitochondrial − + ThDP
ODPA_RAT Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial − + ThDP
ODPB_RAT Pyruvate dehydrogenase E1 component subunit beta, mitochondrial − + ThDP
TKT_RAT Transketolase + + ThDP
ALBU_RAT Serum albumin + + Thiamin 90
ATPB_RAT ATP synthase subunit beta, mitochondrial − + ThDP, ThTP 34
HBA_RAT Hemoglobin subunit alpha-1/2 + + Thiamin 72
HBB1_RAT Hemoglobin subunit beta-1 + + Thiamin 72
HBB2_RAT Hemoglobin subunit beta-2 + + Thiamin 72
DHE3_RAT Glutamate dehydrogenase 1, mitochondrial − + OGDHC 91
DLDH_RAT Dihydrolipoyl dehydrogenase, mitochondrial − + OGDHC, PDHC
SUCA_RAT Succinyl-CoA ligase [GDP-forming] subunit alpha, mitochondrial + − OGDHC 92
CISY_RAT Citrate synthase − + PDHC 92
HSP72_RAT Heat shock-related 70 kDa protein 2 − + OGDHC 93
HSP7C_
RAT Heat shock cognate 71 kDa protein + + OGDHC 93
CH60_RAT 60 kDa heat shock protein, mitochondrial − + OGDHC 93
Table 2.  Identification of the ThDP-dependent enzymes, their protein interactors and other proteins 
known to interact with thiamin and/or derivatives, in the eluates from thiamin (T)- and DMHT-
modified sorbents. The protein partners were included in the table, based on confirmed physical 
interactions according to published data. OGDHC, 2-oxoglutarate dehydrogenase complex; PDHC, pyruvate 
dehydrogenase complex.
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whose orthologs in a variety of eukaryotic species are closely related to bacterial ThiJ kinases involved 
in the biosynthesis of thiamin57. Aldose reductase ALDR_RAT and glyoxalase II GLO2_RAT (present in 
both thiamin and thiazolium proteomes; Supplementary Table S1) detoxify glyoxal and methylglyoxal, 
which increase upon addition of thiamin antagonist, oxythiamin58, or in thiamin-deficient animals59. In 
vitro assays of tissue homogenates from such animals showed that the glyoxalase activity decreased in 
thiamin deficiency and increased upon thiamin repletion59, similarly to the activities of ThDP-dependent 
enzymes. In view of the presence of glyoxalase in the eluates from thiamin and DMHT-modified sorb-
ents, these data favor the glyoxalase activation by thiamin or derivatives, and inactivation by the thiamin 
antagonist oxythiamin. Functional relationship of the ThDP-dependent 2-oxoglutarate dehydrogenase to 
glutamate and γ -aminobutyric acid (GABA)60,61 signaling and metabolism correlates with the presence 
of the glutamate receptor 2 and enzymes belonging to the glutamate and GABA-related pathways in the 
proteomes, such as mitochondrial and cytoplasmic aspartate aminotransferases, glutamine synthetase, 
succinate-semialdehyde dehydrogenase, 4-aminobutyrate aminotransferase (Supplementary Table S1). 
Published data also reveal a number of functional and physical interactions between the proteins eluted 
from the thiamin and/or DMHT-modified sorbents (Table 3). Partial overlapping of the proteins shown 
in Tables  2 and 3 includes HSP-70 and enzymes of the tricarboxylic acid (TCA) cycle with its associ-
ated pathways. These identified proteins may hence be the core components of extended protein-protein 
interacting structures.
In addition to our own analysis of the proteomes according to a strict criterion of experimentally con-
firmed biologically relevant interactions (Tables 2 and 3), we performed automatic database search using 
bioinformatics tools. Supplementary Fig. S2 visualizes different types of interactions between proteins 
of the identified proteomes extracted from the databases by STRING. High interaction density defines 
clusters of proteins involved not only in the expected ThDP-dependent metabolism (including that of 
glutamate; blue circle), but also in signaling through 14-3-3 (red circle). Additional clusters of proteins 
involved in cellular redox state homeostasis (green circle) and Ca2+ regulation (yellow circle) were revealed 
in the thiazolium proteome (Supplementary Fig. S2B), where more proteins were eluted and identified 
(Supplementary Fig. S1 and Table S1). A further study assessed functional classification of the proteins 
in the thiamin and thiazolium proteomes by DAVID and PANTHER. In order to exclude potential bias 
due to overrepresentation of widely studied phenomena (such as, e.g. regulation of proteins by phospho-
rylation, contributing to the term “phosphoprotein”) we used as a reference the published partial brain 
proteomes of DJ-1-binding proteins32 and frontal cortex33. Functional annotation by DAVID (Table  4) 
revealed that the thiamin and thiazolium proteomes are highly enriched with acetylation-related pro-
teins, suggesting an interplay between this newly emerged regulatory post-translational modification and 
thiamin. The same annotation term is highly enriched in the proteome binding to the PD-associated pro-
tein, DJ-1 (parkin-7)32, which is present in the thiazolium proteome (Supplementary Table S1). However, 
proteome of frontal cortex33 is mostly enriched with another annotation term, i.e. phosphoprotein, thus 
supporting specific association of the proteins eluted from the thiamin- and DMHT-modified sorbents 
with acetylation. Nevertheless, phosphoproteins also comprise a significant part of the thiamin and thi-
azolium proteomes, which agrees with the known ThTP-dependent phosphorylation of synaptosomal 
proteins18. However, there is more than a 2-fold difference in orders of magnitude of P-values between 
the first and second most abundant (i.e., with high n) groups of proteins (Table 4). In other words, the 
new relation of the thiamin and thiazolium proteomes to acetylation revealed in this work has much 
more statistical significance compared to other terms. Functional classification by PANTHER indicated 
three major functions of the thiamin- and thiazolium-binding proteins: catalytic activity, binding and 
structural molecule activity (Fig. 1, Molecular function). The binding activity includes proteins involved 
in Ca2+, nucleic acids binding and protein-protein interactions; the structural molecule activity includes 
structural proteins of a cell, such as structural constituents of cytoskeleton and ribosomes. Once again, 
the proteome specificity of the classification is obvious from comparative analysis of the thiamin/thi-
azolium and other proteomes. For example, protein binding function is dominating in the thiazolium 
proteome, whereas nucleic acid binding is the major term in DJ-1 and frontal cortex proteomes (Fig. 1, 
Binding).
Kinetic proof of the thiamin and DMHT binding to abundant enzymes of the thiamin and 
thiazolium proteomes. Other then known thiamin or ThDP-dependent proteins (exemplified in 
Table 2), we were able to detect the interactions with the thiamin and DMHT baits of proteins unknown 
to be thiamin-dependent. High abundance of a protein in the affinity chromatography eluate suggests 
the direct, rather than protein-mediated, interaction of the protein with the bait. Abundance of a protein 
is roughly proportional to the number of identified peptides and sequence coverage, correlating with 
high score values of the protein identification36. The reactivity of the most abundant enzymes towards 
thiamin and DMHT was therefore studied by means of enzyme kinetics. Changes of enzymatic reaction 
rates in the presence of the compounds of interest are sensitive and efficient indicators of the compound 
binding to enzyme. Owing to this, independently of potential biological significance of the binding and 
amplitude of the changes, effects of thiamin and DMHT on the activity of the most abundant enzymes 
in the proteomes should prove their direct interaction with the baits. Because the efficiency and effects 
of ligand binding to the enzymes may be strongly affected by medium conditions, the primary choice for 
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Protein name Interaction Partner
Proteome
References Type of interactionT Tz
Malate dehydrogenase (mitochondrial)
Glutamate dehydrogenase − + 94 Protein-protein interactions
Citrate synthase − + 95 Protein-protein interactions
Aspartate aminotransferase (mitochondrial) + + 96 Protein-protein interactions
Glutamate dehydrogenase
Malate dehydrogenase (mitochondrial) − + 94 Protein-protein interactions
Aspartate aminotransferase (mitochondrial) − + 94 Protein-protein interactions
Pyridoxal kinase Aspartate aminotransferase + + 97 Protein-protein interactions
14-3-3
Pyridoxal kinase + + 98,99 Protein-protein interactions
Profilin − + 100 Protein-protein interactions
Actin + + 100 Protein-protein interactions
Tubulin − + 100 Protein-protein interactions
PP1-alfa − + 98 Protein-protein interactions
Casein kinase II + − 98 Protein-protein interactions
Peroxiredoxin 2 − + 98 Protein-protein interactions
Peroxiredoxin 5 − + 98 Protein-protein interactions
Peroxiredoxin 6 − + 98 Protein-protein interactions
HSP70 + + 98 Protein-protein interactions
Glutamine synthase + − 84,101
Protein-protein interactions Functional 
interaction: concomitant oxidation of 14-3-3 
and glutamine synthase in Amyloid beta 
neurotoxicity
Calmodulin
V-type ATPase, subunit A − + 102 Protein-protein interactions
BASP1 − + 103 Protein-protein interactions
MARCKS − + 104 Protein-protein interactions
Synapsin − + 105 Protein-protein interactions
V-type ATPase (subunits A, B, D, E1) Aldolase A, C + − 106 Protein-protein interactions
BASP1
MARCKS − + 107 Protein-protein interactions
Actin − + 108 Protein-protein interactions
MARCKS
HSP70 − + 109 Protein-protein interactions
Actin − + 108 Protein-protein interactions
Synapsin
Rab3A − + 110
Functional interaction; Rab3A inhibited 
synapsin I binding to F-actin, as well as 
synapsin-induced actin bundling and vesicle 
clustering
Spectrin − + 111 Protein-protein interactions
F-actin − + 112 Protein-protein interaction in a phosphorylation-dependent manner
Peroxiredoxin 6
Glutation-S-transferase Pi (GST Pi) − + 113
Functional interaction: oxidation of the 
catalytic cysteine in Prdx6 is required for its 
interaction with GST Pi
Amyloid β A4 protein − + 114
Functional interaction: Prdx 6 protects 
PC12 cells from Aβ 25-35-induced 
neurotoxicity
Amyloid β A4 protein
Serum Albumin − + 115 Protein-protein interactions
Protein phosphatase 2A (PP2A) − + 116 Protein-protein interactions (with amyloid β )
Glutamate receptor 2 (GRIA2)
Tubulin − + 117 Protein-protein interactions
WW domain-binding protein 2 (WWP2) + − 118
Functional interaction: ADAR2 protein 
levels are regulated by WWP2 and this may 
have downstream effects on GRIA2
Casein kinase II + − 119 Functional interaction: casein kinase II phosphorylates GRIA2
Ubiquitin-dependent proteins
Ubiquitin carboxyl-terminal hydrolase 1 − + 
120 Proteins and targets of ubiquitin systemActin, cytoplasmic + + 
Tubulin, alpha chain + + 
Continued
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the enzymatic assays was Ringer-bicarbonate buffer, used for protein application to the affinity columns. 
This allowed us to mimic conditions of potential protein interaction with the affinity baits.
As seen from Supplementary Table S1, mitochondrial malate dehydrogenase (MDH2) was identified 
in the thiamin proteome with the highest confidence score and peptide number; in the thiazolium pro-
teome, it occupied the second place after the known thiamin ligand albumin (Table 2). Direct interaction 
of MDH2 with both the thiamin and DMHT baits was supported by kinetic assays of MDH2 in the 
extracts of brain mitochondria. As seen in Fig. 2A, thiamin and DMHT affected enzyme activity starting 
from concentrations as low as 10 μ M. Remarkably, a 2-fold activation by thiamin was not mimicked by 
its structural analog DMHT, yet binding of the latter was obvious from its inhibitory effect on MDH2 
(Fig. 2A). The dependence of enzymatic response, such as activation or inhibition, on the effector struc-
ture is a known feature of allosteric regulation.
Pyridoxal kinase (PdxK) was identified in the thiamin proteome with the next highest confidence 
score after MDH2. In the thiazolium proteome, the enzyme was also identified with high score and 
peptide number, following MDH2 after abundant cellular proteins forming multiple protein-protein 
interactions, such as actin, tubulin and 14-3-3 proteins (Supplementary Table S1). Because high concen-
trations of Mg2+ and Ca2+ in the Ringer-bicarbonate buffer inhibit recombinant human PdxK, its reac-
tivity with thiamin and DMHT was assayed under standard conditions established earlier53. Figure 2B 
Protein name Interaction Partner
Proteome
References Type of interactionT Tz
Heat shock cognate 71 kDa protein + + 
Dihydropyrimidinase-related protein 2 + + 
14-3-3 protein zeta/delta + + 
Guanine nucleotide-binding protein G(o) subunit 
alpha − + 
Synapsin-2 − + 
Amyloid β A4 protein − + 
Endophilin
Synaptojanin − + 121 Protein-protein interactions
PP1-alpha − + 122 Protein-protein interactions
Aldose reductase
Hydroxyacylglutathione hydrolase mitochondrial 
(glyoxalase II) + − 123
Aldose reductase, glyoxalase I,and 
glyoxalase II are involved in the metabolism 
of methylglyoxal
Tubulin − + 124 Protein-protein interactions
Table 3.  Physical and functional interactions between the proteins of the thiamin and thiazolium 
proteomes of rat brain synaptosomes. HSP70, Heat shock 70 kDa protein; BASP1, Brain acid soluble 
protein 1; MARCKS, Myristoylated alanine-rich C-kinase substrate.
Proteome
Thiamin (54) Thiazolium (144) Dj-1 (312) Frontal cortex (395)
Annotation term n P-value Annotation term n P-value Annotation term n P-value Annotation term n P-value
1. Acetylation 33 9*10−17 1. Acetylation 87 4*10−41 1. Acetylation 146 10−89 1. Phospho-protein 250 2*10−31
2. Oxygen carrier 4 5*10−7 2. Phosphoprotein 97 2*10−20 2. Ribonucleo-protein 41 3*10−34 2. Coiled coil 92 9*10−16
4. Phospho-protein 33 2*10−6 3. Cytoplasm 61 4*10−14 3. Phospho-protein 143 1*10−27 4. Nucleus 132 8*10−9
8. Nucleotide-binding 12 10−4 7. Nucleotide-binding 34 2*10−6 11. Nucleotide-binding 45 9*10−9 14. Nucleotide-binding 64 5*10−6
Table 4.  Functional annotation of the thiamin and thiazolium proteomes of rat brain synaptosomes 
in comparison to published partial brain proteomes of DJ-1-binding proteins32 and frontal cortex33. 
DJ-1 protein was detected in the thiazolium proteome, whereas proteome of frontal cortex represents 
independently purified fraction of brain proteins. The total number of proteins in the proteomes: 
thiamin—57, thiazolium—150, Dj-1 (parkin7)—755, frontal cortex—412. The total numbers of genes 
accepted by DAVID from the identified proteomes are indicated in the table in parenthesis. SP_PIR_
KEYWORDS category was used to characterize the proteomes. The first two annotation terms which are 
most significantly enriched, are given for each proteome. The third term with significant P-value is chosen 
according to the protein number n indicating how many proteins of the proteomes relate to this term. 
Nucleotide-binding annotation term is included to show a relatively low significance of enrichment of the 
thiamin and thiazolium proteomes with the nucleotide binding proteins. The number preceding the term 
name corresponds to the position of its P-value in the DAVID-generated output.
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shows that both compounds affected PdxK activity, supporting the direct interaction of the enzyme with 
the corresponding baits of the affinity sorbents. The low affinity of the thiamin compounds to PdxK 
(10−4– 10−3 M) in the kinetic assays, compared to the other tested enzymes (i.e. malate and glutamate 
dehydrogenases; 10−5– 10−4 M) could be due to specific post-translational modifications of brain PdxK, 
not occurring in the recombinant enzyme used in our kinetic studies. Because detailed enzymological 
characterization of recombinant human PdxK was far beyond the scope of the present study, we limited 
our kinetic studies of PdxK to the model system established earlier for recombinant human enzyme53.
Mitochondrial glutamate dehydrogenase (GDH) was identified with high score as an abundant enzyme 
in the thiazolium, but not thiamin proteome (Supplementary Table S1). Indeed, GDH activity assays in 
Ringer-bicarbonate buffer indicated that the effect of DMHT was of higher amplitude compared to that 
of thiamin (Fig. 2C). Hence, it is probably not thiamin, but some of its natural derivatives that bind at the 
DMHT site. In any case, the kinetic data presented in Fig. 2C are in good accord with the identification 
of GDH in the thiazolium proteome only. Statistical significance of the effects shown in Fig. 2 was con-
firmed by reproducing the results with different enzyme preparations, including commercially available 
pure enzymes, and under variable sets of conditions, as presented in the following sections.
All together, our kinetic studies provide a proof of concept for the thiamin dependence of those pro-
teins which were found abundant in the eluates from affinity sorbents.
Localization of thiamin-binding sites in MDH, GDH and pyridoxal kinase by structural and 
kinetic approaches. In order to localize potential binding sites for thiamin or its derivatives in the 
enzymes shown to directly interact with thiamin and DMHT in kinetic studies (Fig. 2), we made advan-
tages of available structural information on binding sites for thiamin and derivatives23 and on the solved 
3D structures of MDH, GDH and pyridoxal kinase. Because all these enzymes interacted with DMHT 
(Fig.  2), which mimics the thiazolium part of thiamin, the binding patterns were generated using the 
structures of thiamin- and thiazol-dependent enzymes, such as human thiamin diphosphokinase and 
bacterial 4-methyl-5-(2-hydroxyethyl)-thiazole kinase (ThiM). In addition, the pattern based on the 
known characteristic motif of the ThDP-dependent enzymes48 was employed for the PROSITE search of 
protein sequences with potential thiamin-binding sites. When creating the binding patterns for thiamin 
and derivatives in the enzymes (as described in Methods) we were also interested in finding common 
and thiamin-specific elements involved in binding. In this regard, the protein residues in the vicinity 
Figure 1. Classification by PANTHER of proteins of the thiamin, thiazolium, DJ-1-binding32 and frontal 
cortex33 proteomes according to their molecular functions and binding properties. Color code of the 
circle diagram sections are shown in the figure.
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of thiamin heterocycles were considered more promising, because the phosphate groups are present 
in many other compounds. Examination of different protein complexes with thiamin and derivatives 
pointed to a high occurrence of serine and threonine residues neighboring the thiazolium ring of thia-
min. In particular, the bacterial thiamin-binding periplasmic protein ThiB (synonyms tbpA, yabL) which 
is a part of the thiamin ABC (ATP-binding cassette) transporter (the complex responsible for the uptake 
of thiamin and its phosphate derivatives47) exhibited a stretch of serine residues whose conformation 
and position relative to the thiamin heterocycles were highly similar to those found in thiamin diphos-
phokinase. We used this motif (Fig. 3B) to construct the pattern [ILV][ST][ST][ST]N which was found 
to be present in our proteins of interest. Furthermore, we shall refer to this hybrid pattern as the thiamin 
diphosphokinase/ThiB pattern, in order to distinguish it from the other one based solely on thiamin 
diphosphokinase.
Figure 3 shows the four employed patterns, i.e. the thiamin diphosphokinase- and thiamin diphos-
phokinase/ThiB-based patterns (A, B), the pattern present in ThDP-dependent enzymes (C, D) and the 
ThiM-based pattern (E, F), in the corresponding enzyme complexes with ThDP or thiazole, both in oligo-
meric structures and at a close view. The proteins relevant to this study, i.e. those shown to interact with 
thiamin and DMHT by both affinity chromatography and kinetics, were selected among the PROSITE 
hits to the patterns. The thiamin-binding pattern of thiamin diphosphokinase was found in bacterial 
pyridoxal kinase PDXK_ECOLSM. The hybrid thiamin diphosphokinase/ThiB-based pattern matched to 
animal pyridoxal kinase PDXK_SHEEP, fungal glutamate dehydrogenase DHE2_ACHKL and 10 malate 
dehydrogenases, including four bacterial, five archaeal and one eukaryotic (MDH1B_DANRE) species. 
The thiazole-binding pattern of ThiM was found within 13 sequences of pyridoxal kinase isoform PdxY 
(from different Burkholderia and Pseudomonas strains), three sequences of bacterial and fungal gluta-
mate dehydrogenases (DHE2_ACHKL), and 36 sequences of malate dehydrogenases from bacteria and 
plants. The ThDP-binding motif matched to the different parts of sequences from MDH1B_HUMAN 
and MDH_DESRM. The pattern-comprising parts of the alignments of the thiamin/DMHT-binding 
enzymes are given in Fig. 4. Using multiple sequence alignments, the patterns were identified in the 3D 
protein structures as shown in Fig. 5. Available 3D structures of the enzymes which in our study were 
shown to bind thiamin and DMHT, included porcine cytosolic MDH1 (PDB ID: 4MDH), human mito-
chondrial MDH2 (PDB ID: 2DFD), archeal MDH (PDB ID: 2 × 0R), bacterial MDH (PDB ID: 1B8U), 
Figure 2. Influence of thiamin and DMHT on activities of the enzymes abundant in the thiamin and 
thiazolium proteomes. (A)—mitochondrial malate dehydrogenase (MDH2) assay in Ringer-bicarbonate 
buffer, pH 7.4, at 0.01 mM oxaloacetate and 0.02 mM NADH; (B)—human recombinant pyridoxal 
kinase (PdxK) assay in 75 mM NaBES, pH 7.3, at 0.125 mM pyridoxal and 0.1 mM ATP; (C)—glutamate 
dehydrogenase (GDH) assay in Ringer-bicarbonate buffer, pH 7.4, at 0.1 mM 2-oxoglutarate and 0.02 mM 
NADH. Activities are expressed in micromoles of substrate transformed per min per mg of protein. Each 
data point represents the average ± SEM from at least triplicate assays. When error bars are not visible, 
they are within the symbol size. The experimental curves were approximated by hyperbolic functions using 
SigmaPlot 12.0. Statistical significance (p ≤ 0.05, t-test) of the differences compared to the control values is 
marked by asterisks.
www.nature.com/scientificreports/
1 2Scientific RepoRts | 5:12583 | DOi: 10.1038/srep12583
PdxK from sheep (PDB ID: 1RFT), the pyridoxal kinase isoform PdxY from E. coli 62 (PDB ID: 1TD2), 
and bovine GDH (PDB ID: 3MVQ).
The patterns in the PROSITE-predicted protein hits to the enzymes which were shown to bind thi-
amin and DMHT (Fig.  5) were compared to the original patterns (Fig.  3). We considered the preser-
vation of the 3D pattern conformation, the conservation of the pattern-comprising protein structure 
and co-localization of different patterns in one enzyme as enhancing the probability that the pattern 
belongs to a functional thiamin-binding site (Fig.  2). In particular, using multiple sequence alignment 
and the PDB ID 1IB6 structure of E. coli MDH, we found that spatial conformation of the motif in 
Figure 3. Patterns for binding of thiamin and derivatives. A,B—ThDP binding patterns (marked in green 
and pink) in thiamin diphosphokinase PDB ID: 3S4Y (A—dimer, B—close view). C,D—ThDP-binding motif 
of ThDP-dependent enzymes (marked in orange) in transketolase (C—dimer, PDB ID: 3OOY, D—close view, 
PDB ID: 3MOS). E,F—Binding pattern of 4-methyl-5-(2-hydroxyethyl)-thiazole (marked in yellow) in ThiM 
PDB ID: 1C3Q (E—trimer, F—close view). Essential residues of the patterns are shown as sticks in the same 
color as the pattern. The active site metal ions are shown in green; other ligands are in cyan; heteroatoms are 
presented according to the common color code: red for oxygen, blue for nitrogen, yellow for sulfur, orange 
for phosphorus.
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MDH_DESRM differs from the original one presented in Fig. 3D, not supporting functional significance 
of the motif found in MDH_DESRM. The same applied to the thiamin diphosphokinase/ThiB pattern in 
the sequence of MDH1B_DANRE (residues 157–161). In the available 3D structures of MDH the pat-
tern residues are found within a α -helix instead of the β -sheet present in the original pattern (Fig. 3B). 
In contrast, the ThDP-binding motif found in the putative and still uncharacterized human isoform 
MDH1B (Fig. 4) not only had an appropriate conformation (as shown in Fig. 5A,B), but also co-localized 
with the two thiazole-binding patterns found in other MDH sequences (Figs  4 and 5). The exclusive 
presence of the ThDP-binding motif in no other MDH but MDH1B (Fig.  4A), was due to the lack of 
significant residues of the motif in the two known isoforms of MDH. The motif G[DE][GA]x(24,30)
NN bind Mg2+ forming a bridge to the diphosphate group of ThDP (Fig. 3D). Moreover, the essential 
acidic residue of the G[DE][GA] triplet of the motif was substituted, in the known MDH isoforms, by 
a conserved arginine residue (Fig. 4A) interacting with malate (Fig. 5B). Thus, the ThDP-binding motif 
may bind Mg2+ in the uncharacterized MDH1B isoform but not in the known isoforms of cytosolic and 
mitochondrial MDHs. Nevertheless, kinetic studies on known MDH isoforms agree with their thiamin 
binding site near the malate/oxaloacetate binding site, i.e. near the site having the conserved arginine 
residue in common with the apparently different ThDP-binding motif (Fig.  5B). As shown in Fig.  6A, 
the thiamin-dependent activation of mitochondrial MDH2 disappeared upon saturation with oxaloac-
etate, but not upon saturation with NADH. Similar data were obtained using commercial preparation 
of mitochondrial MDH purified from porcine heart (Fig.  6B). Because thiamin stimulates the MDH2 
Figure 4. Local multiple sequence alignments of sequence parts comprising the thiamin and derivatives-
binding patterns found in the abundant enzymes of the thiamin and thiazolium proteomes. (A)—malate 
dehydrogenases; (B)—pyridoxal kinases; (C)—glutamate dehydrogenases. The pattern residues are marked 
above or below the sequences dependent on the vicinity of the sequences where they are found. The pattern 
color code is as in Fig. 3, except for the two PROSITE hits to thiazole-binding pattern of ThiM in MDH (A), 
where the yellow-green color marks the second hit to the pattern. The pattern residues common with those 
of the active sites are marked by asterisks. The conservation is given below the alignments in (A and C). In 
(B), the conservation above and below the alignment corresponds to PdxK and PdxY, present in the upper 
and lower parts of the alignment, correspondingly. Protein IDs and accession codes, according to UNIPROT 
database, precede the alignments.
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reaction at a low saturation with oxaloacetate only, the effect is obviously due to increased affinity of 
the enzyme-thiamin complex to oxaloacetate. The kinetic data thus agree well with an allosteric site 
for thiamin near the oxaloacetate/malate site, pinpointed by the ThDP-binding motif (Fig.  5B). In the 
dimer structure, additional residues for the thiamin binding to mitochondrial MDH2 could be provided 
by the proximal thiazole-binding pattern of the neighboring subunit (Fig. 5A). The hits to this pattern 
were found by PROSITE in cytosolic MDH1 only, because mitochondrial MDH2 has organelle-specific 
sequence deletions in this region (Fig.  4A). However, the lacking third part of the pattern (AA duplet 
Figure 5. Thiamin and derivatives binding patterns in the 3D structures of the abundant enzymes of 
thiamin and thiazolium proteomes. The pattern color code and other details are as in Fig. 3. (A)—Dimer 
of porcine cytosolic MDH1 with NAD+ bound (PDB ID: 4MDH). (B)—Close view of the ThDP-binding 
motif of ThDP enzymes in the monomer of human mitochondrial MDH2 with NAD+ and D-malate in the 
active site (PDB ID: 2DFD). (C)—Dimer of E. coli PdxY with pyridoxal bound to the active site (PDB ID: 
1TD2). (D)—Close view of the thiazole and thiamin-binding patterns in the monomer of sheep PdxK with 
bound pyridoxamine and phosphomethylphosphonic acid adenylate ester (PDB ID: 1RFT). (E)—Trimer of 
bovine GDH with NADPH and glutamate bound to the active sites (PDB ID: 3MVQ). (F)—Close view of 
the thiazole-binding pattern of ThiM near the active site of bovine GDH with NADPH and glutamate bound 
(PDB ID: 3MVQ).
www.nature.com/scientificreports/
1 5Scientific RepoRts | 5:12583 | DOi: 10.1038/srep12583
marked in yellow, Fig. 4A) was found in the mitochondrial sequence several residues later (AA before the 
conserved D, Fig. 4A), suggesting a complete thiazole-binding pattern in mitochondrial MDH2 as well.
Interestingly, the thiamin diphosphokinase/ThiB-based β -strand with the essential triplet of S/T resi-
dues was revealed in the two positions of the sequences in some bacterial and archaeal MDHs (Fig. 4A). 
Supplementary Fig. S3A shows that in archaeal MDH the thiamin-binding pattern localized close to 
the NAD+/malate binding site. In bacterial MDH (Supplementary Fig. S3B) the pattern belongs to 
β -strand which covers the NAD+-binding site, separating it from the solvent. Thus, although different 
thiamin-binding patterns could be found in different sequences of MDH, they all co-localize in the pro-
tein 3D structure near the enzyme active site.
The finding of the thiazole-binding pattern in cytosolic MDH1 forecasts the interaction of thiamin 
with this isoform too. As shown in Fig.  6C, cytosolic MDH showed a strong inhibition by both thi-
amin and ThDP, suggesting the diphosphate group to be not essential for the inhibitory effect. The 
thiamin-dependent inhibition of cytosolic MDH1 and the activation of the mitochondrial isoform 
(Figs  2A,6A) agree with the structural differences of the enzyme sequences in the regions where the 
ThDP-binding motif and thiazole-binding pattern were found (Fig. 4A). However, also in the cytosolic 
isoform the thiamin effect was dependent on saturation with oxaloacetate (Fig. 6D), in agreement with 
partial overlapping between ThDP-binding motif and oxaloacetate/malate-binding site (Fig. 5B).
As mentioned above, PdxK from E. coli and PdxK from sheep (Fig. 4B) were shown to possess the 
thiamin-binding patterns based on thiamin diphosphokinase only (green, Figs 3A,B and 4B) or together 
with ThiB (pink, Figs  3A,B and 4B). The thiazole-binding pattern (yellow in Figs  3E,F and 4B) was 
found in an isoform of pyridoxal kinase existing in bacteria (PdxY). Although the two isoforms exhibit 
Figure 6. Regulatory effects of thiamin and derivatives on partially isolated rat brain enzymes MDH2 
(A), MDH1 (C,D), GDH (E,G) and purified porcine mitochondrial malate dehydrogenase (B) and bovine 
liver GDH (F,H). ThDP—thiamin diphosphate; ThTP—thiamin triphosphate; AThTP—adenylated thiamin 
triphosphate. (A,B,D–F)—Dependence on the substrate saturation. (C,G,H)—Dependence on concentrations 
of thiamin and derivatives. Shades of grey define different saturations with the dicarboxylic acid substrate 
(i.e. oxaloacetate or 2-oxoglutarate (2-OG), generically referred as “acid” in the figure) and NADH as 
indicated in the common legend to the figures (A,B,D–F). Bar patterns define varying concentrations of 
ThTP and AThTP as shown in the common legend to the figures (G and H). The enzymes were assayed in 
Ringer-bicarbonate (A–D,G,H) or 100 mM Tris-HCl buffers (E,F), pH 7.5, using the following substrate 
concentrations: (A,B and D)—0.01 mM oxaloacetate (low acid); 0.3 mM oxaloacetate (high acid); 0.02 mM 
NADH (low NADH); 0.14 mM NADH (high NADH); (C)—0.01 mM oxaloacetate, 0.02 mM NADH; (E,F)—
0.1 mM 2-oxoglutarate (low acid), 2.5 mM 2-OG (high acid); 0.02 mM NADH (low NADH); 0.2 mM NADH 
(high NADH); G,H—0.1 mM 2-OG, 0.2 mM NADH.
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high sequence, structure and function similarities63, their sequence alignment in the pattern-comprising 
regions, i.e. the local consensus in these regions, favors different binding of the thiamin compounds to 
the isoforms (Figs 4B and 5C,D). Obviously, this is the reason of the differential PROSITE mapping of 
the patterns to the isoforms, as mentioned above. Along with the isoform-specific conservation of the 
essential residues of the patterns, the patterns have different localization in 3D structures. As seen from 
Fig. 5C,D, the thiamin-binding residues of the thiamin diphosphokinase- (green, better correspondent to 
PdxK) and ThiM-based (yellow, better correspondent to PdxY) patterns occupy positions distal from the 
active site. Owing to this, both patterns would define an allosteric binding site for thiamin or derivatives. 
The site is likely to communicate with the pyridoxal-binding site through the protein structure. In par-
ticular, the β -sheets (green and yellow) and a loop (yellow) distant from the thiamin binding residues of 
the patterns are in the vicinity of the substrate pyridoxal (Fig. 5D), and may thus transfer a signal between 
the thiamin- and pyridoxal-binding sites. The information transfer between the sites may also involve 
subunit interface close to the pattern residues (Fig. 5C). In contrast, the thiamin diphosphokinase/ThiB 
(pink) pattern found in PdxK only (Fig.  4B), localizes close to the ATP-binding site (Fig.  5C,D). As a 
result, in the PdxY isoform found in bacteria, structural data suggest an allosteric site for thiamin inter-
acting with the pyridoxal site. In the PdxK isoform, found in both bacteria and mammals, also a second 
site for thiamin binding, which is near to the ATP site, is suggested by the thiamin diphosphokinase/
ThiB pattern (pink, Fig. 5C,D). Kinetic study using the model system with homogeneous recombinant 
human PdxK is in good accordance with the structural hints for the two thiamin/derivative-binding sites 
in PdxK. As seen from Fig.  7, thiamin is competitive towards pyridoxal and non-competitive towards 
ATP. In contrast, ThDP is non-competitive towards pyridoxal but competitive towards co-substrate ATP 
(Fig. 8). Although the relative inhibition constants for thiamin and ThDP (Table 5) are too high to be 
physiologically relevant, this is most probably due to the reasons discussed above, such as the lack of 
post-translational modifications in recombinant human PdxK or the absence of specific ligands in the 
assay medium. Nevertheless, the kinetic study defines the different mechanisms of inhibition of PdxK 
by thiamin or ThDP. While thiamin rather affects the pyridoxal binding, ThDP interferes with binding 
ATP (Table 5). This agrees with the two binding sites for thiamin compounds in PdxK, as suggested by 
localization of the thiamin-binding patterns in the 3D structure on Fig. 5C,D. The ATP-binding site may 
Figure 7. Kinetic analysis of human pyridoxal kinase inhibition by thiamin at varied substrate pyridoxal 
(A) or ATP (B) concentrations, using Lineweaver-Burk (left panel) and secondary plots (right panel). The 
thiamin concentrations in the Lineweaver-Burk plots are: • 0 mM, ■ 1.0 mM, ▲ 2.5 mM, ▼ 5.0 mM, ◆ 
9.0 mM and ◊ 15 mM. All parameters are the average of two or three independent determinations, with SD 
less than ± 5%.
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partially overlap with the ThDP binding site through the residues binding the diphosphate group present 
in the two compounds. Structural difference between thiamin and pyridoxal favor the allosteric binding 
of thiamin at a separate site, decreasing the affinity to pyridoxal (Table 5) through information exchange 
between the allosteric and active sites (Fig. 5D) as discussed above.
The PROSITE scan against the thiazole-binding pattern of ThiM revealed three GDH hits: DHE4_
EMENI, DHE2_PSEAE and DHE2_ACHKL. DHE2_ACHKL was also found when searched using the 
thiamin diphosphokinase/ThiB-based pattern. However, DHE2_PSEAE and DHE2_ACHKL, do not 
align with mammalian GDHs, and the 3D structures for these DHE2 are not available. Owing to this, 
the PROSITE hits to these of archeael and bacterial glutamate dehydrogenases could not be taken into 
account for analysis of the pattern localizations. Nevertheless, the existence of the thiamin-binding pat-
terns in different types of GDHs favors physiological significance of potential GDH regulation by thiamin 
compounds. In contrast, the eukaryotic enzyme from Aspergillus nidulans (DHE4_EMENI) did align to 
mammalian GDHs. The alignment (Fig. 4C) shows that the absence of the PROSITE hit to the pattern in 
animal GDHs is due to a shorter linker between the essential residues of the pattern (residues between 
40 and 50 of the alignment in Fig. 4C). With this exception, the pattern occupies a conserved part of the 
GDH sequence, and its essential residues are mostly conserved throughout species. It is worth noting 
that the original thiamin binding pattern in the ThiM trimer was formed by regions belonging to the 
Figure 8. Kinetic analysis of human PdxK inhibition by thiamin diphosphate at varied pyridoxal (A) or 
ATP (B) concentrations, using Lineweaver-Burk (left panel) and secondary plots (right panel) The thiamin 
concentrations in the Lineweaver-Burk plots are: • 0 mM, ■ 1.0 mM, ▲ 2.5 mM, ▼ 5.0 mM, ◆ 9.0 mM and 
◊ 15 mM. The points present average values of two or three independent determinations, with the SD less 
than ± 5%.
Inhibitor Variable substrate Fixed substrate Type of inhibition Ki (mM)
Thiamin
Pyridoxal MgATP Competitive 2.2
MgATP Pyridoxal Non-competitive 6.6
ThDP
Pyridoxal MgATP Non-competitive 10.4
MgATP Pyridoxal Competitive 3.3
Table 5.  Parameters and mechanisms of inhibition of PdxK by thiamin and ThDP.
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neighboring subunits (Fig. 3E,F). In the trimer of GDH (PDB ID: 3MVQ) no such interaction between 
the patterns is observed (Fig. 5E). However, general structure of the pattern (helix-β -sheet-helix) is pre-
served, and many loops in the pattern-surrounding regions of GDH may provide additional residues to 
bind thiamin and/or its derivatives (Fig. 5F). Formation of the thiamin-binding site in GDH by the resi-
dues from a single subunit may explain shortage of the linker between the second and third parts of the 
pattern in animal GDH compared to the original ThiM-based pattern found in DHE4_EMENI (Fig. 4C). 
Overall, the residues of the thiazol-binding pattern in GDH form a plausible binding site, which is 
very close to those of NAD(P)H (3.25 Å) and glutamate/2-oxoglutarate (4.48 Å) (Fig.  5F). Moreover, 
the thiazole-binding pattern has one residue in common with the NAD(P)H-binding site (Fig. 4C, con-
served N60 in the alignment). Results of kinetic study were in good accord with such localization of the 
thiamin-binding pattern. At low NADH saturation, 1 mM ThDP inhibited both the enzyme from brain 
mitochondrial extract and purified commercial GDH from bovine liver (Fig.  6E,F). At high NADH 
saturation, the inhibition was not observed with the purified GDH, further supporting partial overlap-
ping of the ThDP and NADH binding sites on GDH. Instead, a slight activation, similar to the thiamin 
effect in Fig. 2C, was seen (Fig. 6F). With the brain enzyme from mitochondrial extract, more complex 
effects of ThDP were observed at high NADH, as the effects depended on the 2-oxoglutarate concen-
tration (Fig. 6E). At low 2-oxoglutarate and high NADH concentration, a slight activation (within 20%) 
was observed at 1 mM ThDP concentration, similarly to that of the purified GDH. However, increasing 
2-oxoglutarate and NADH concentration to saturating levels led to an inhibition effect at 1 mM ThDP 
concentration (Fig.  6E), which was not observed with the purified enzyme (Fig.  6F). The complexity 
of the ThDP-induced effects on GDH (Fig.  6E,F) suggests multiple binding modes of ThDP to GDH, 
similar to those revealed for the GDH regulation by phosphorylated nucleotides and dinucleotides, such 
as adenosine diphosphate (ADP), guanosine triphosphate (GTP) and NAD(P)H64. Dependent on con-
centration, all these diphosphate-comprising nucleotides could bind at the NAD(P)H, GTP and ADP 
sites of GDH. Owing to this, the difference between the purified and extracted GDH regarding the 
ThDP effect at saturation concentrations of both 2-oxoglutarate and NADH (Fig. 6E,F) could be due to 
a higher residual saturation of the non-purified mitochondrial enzyme with the GDH activator ADP. In 
the reaction medium, 1 mM ThDP could substitute endogenous ADP at the GDH activation site. If the 
allosteric activation by ADP cannot be mimicked by ThDP, the substitution would decrease the GDH 
activity due to decreased ADP activation. This assumption was supported by measuring the ThDP effect 
on the purified GDH at saturating NADH and 2-oxoglutarate concentrations in the presence of ADP. 
2 mM ADP was shown to activate purified GDH about two-fold, with the activation abolished upon 
addition of 1 mM ThDP. Insofar, a residual saturation of non-purified mitochondrial GDH with endog-
enous ADP could be responsible for the difference between the purified GDH and the enzyme in mito-
chondrial extract regarding the ThDP effect at high saturation of NADH and 2-oxoglutarate (Fig. 6E,F). 
The residual saturation with endogenous regulators, along with tissue specificity of, e.g., posttranslational 
modifications, could also contribute to the different amplitudes of the effects in the mitochondrial and 
purified enzymes shown in Fig. 6.
Although both thiamin and ThDP affected GDH activity, the amplitudes of their effects and concen-
tration dependence were higher when DMHT was taken into consideration (Fig. 2). The better binding 
of DMHT to GDH was obvious also from the GDH identification in the eluate from the DMHT-modified 
sorbent only (Supplementary Table S1). Moreover, both mitochondrial and purified GDH were shown 
to be activated in the presence of low concentrations (1–10 μ M) of thiamin triphosphate and adenylated 
thiamin triphosphate (Fig.  6G,H), suggesting that the binding of thiamin, ThDP and DMHT partially 
mimics the GDH regulation by some other thiamin derivatives. High efficiency of the GDH activation 
by the above-mentioned non-coenzyme derivatives of thiamin points to GDH as an enzyme target of 
these compounds in vivo. A higher effect of the compounds on the purified GDH (Fig. 6H) compared 
to the enzyme in mitochondrial extract (Fig.  6G) simulates the difference of the ThDP effect on the 
two enzymes at saturating NADH concentration (Fig. 6E,F). Based on the existing64 and presented data 
(Fig. 6), a complex interaction of adenylated thiamin triphosphate and ThTP with the regulatory (ADP 
and GTP) and catalytic (NAD(P)H) nucleotide sites of GDH may be suggested, which certainly requires 
future studies.
Discussion
Novel targets of thiamin compounds in brain. To advance the understanding of molecular mech-
anisms of thiamin action in brain, we aimed at the identification of the synaptosomal proteins binding 
and/or transforming thiamin or its derivatives. The protocol of partial purification of a subset of such 
proteins included affinity chromatography on sorbents derivatized with thiamin or its thiazolium hetero-
cycle covalently bound to a spacer. The approach was elaborated in the previous work to obtain a fraction 
of synaptosomal proteins which were able to bind labeled thiamin and hydrolyze thiamin phosphates, 
with thiamin triphosphate being the best substrate13,26. Affinity chromatography on sorbents carrying 
thiamin or its derivatives was earlier used to purify the thiamin- and ThDP-dependent enzymes, such 
as thiamin diphosphokinase65, pyruvate decarboxylase35 and pyruvate dehydrogenase66. In these studies, 
thiamin- and ThDP-dependent enzymes were not always successfully eluted by competitive desorption 
in the presence of thiamin or ThDP in the elution buffer. Most probably this was due to the protein 
conformational changes after the thiamin/ThDP binding, which have been structurally characterized 
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in the recent years22. Because our work aimed at simultaneous identification of the unknown subset of 
synaptosomal thiamin- or thiamin derivative-binding proteins, an established protocol for the elution of 
such proteins in the presence of optimized salt and urea concentrations was preferred14,15,17,26. Besides a 
thiamin-modified sorbent, we also used a sorbent derivatized with the thiamin-specific thiazolium ring 
(DMHT-modified sorbent). This was done to reveal the proteins binding not only to the thiamin sorbent, 
but also to the sorbent including the unique thiazolium part of the thiamin molecule. The binding of the 
same proteins and/or protein clusters to these two sorbents was considered as evidence for the binding 
specificity to the thiazolium-possessing thiamin compounds. Interaction with the baits comprising the 
other parts of the thiamin structure, such as phosphates or aminopyrimidine residues, would not sup-
port the specificity, as the latter moieties or their analogs occur in abundant nucleotides interacting with 
many proteins. Besides, as specified in Introduction and discussed in details below, DMHT was shown 
to regulate neurotransmission. Moreover, the DMHT similarity with the thiamin degradation products 
could help fishing out potential targets of such products, which may acquire specific significance upon 
application of pharmacological doses of thiamin.
Whereas affinity chromatography aimed to purify single enzymes uses homogeneity criterion and 
enzyme specific activity to analyze the enzyme elution and the role of the bait structure, different strate-
gies are employed in the high throughput approaches for isolation of a subset of proteins with their phys-
iologically relevant yet unknown specific activities. In our study, we substantiate the specific binding of 
proteins to the baits through integration of results obtained by independent approaches. Our conclusion 
on the thiamin dependence of well-defined proteins or pathways does not solely rely on their binding 
to the thiamin- and DMHT-modified sorbents. The abundant proteins identified in the eluates from 
the affinity chromatography were independently tested for their interaction with the baits using enzyme 
kinetics and structural analysis. Besides, in view of emerging recognition of supramolecular structures 
in transmitting signals and organizing metabolism, we consider as biologically relevant not only the 
direct interactions of proteins with the baits, but also protein-mediated interactions. We revealed such 
interactions in our proteomes by both manual (Tables 2 and 3) and bioinformatics (Supplementary Fig. 
S2) analysis. The thiamin and thiazolium proteomes comprised many proteins (Supplementary Table S1, 
Fig.  1), clusters (Supplementary Fig. S2) and interactions (Tables  2 and 3, and Supplementary Fig. S2) 
which are shared by the two proteomes. The similarity provides a measure of the binding specificity in 
high throughput experiment, where it is not possible to check each protein regarding specificity of its 
interaction with the bait. As a result, affinity chromatography to isolate a subset of proteins generates 
leads for a further, more focused examination of the thiamin dependence of the attractive proteins or 
protein clusters identified in the eluates. In the current work, the specificity of the interaction with the 
thiamin and DMHT baits was proven for abundant enzymes of the proteomes by in vitro enzymatic 
assays and structural analysis. This study revealed mitochondrial and cytosolic malate dehydrogenases, 
glutamate dehydrogenase and pyridoxal kinase as novel targets of thiamin compounds in brain. These 
enzymes do not require ThDP as coenzyme. However, their saturation with the substrates (dicarbo-
xylates, pyridoxal) structurally different from thiamin and/or its derivatives seems to be regulated by 
binding of thiamin compounds. The structural difference between substrates and effectors suggests 
allosteric binding sites, which are independently favored by our structural analysis. The observed effects 
on MDH, GDH and PdxK enzyme activity are highly dependent on the thiamin derivative used in 
the assay, on substrate saturation and medium conditions (Figs  2,6,7 and 8). Variations in the level of 
enzyme post-translational modifications and saturation with endogenous regulators may contribute to 
the quantitative differences between different enzyme preparations or between the enzymes in rat brain 
mitochondrial extract and purified commercial enzymes from other sources. However, significant acti-
vation of MDH2 (1.7-fold, Fig. 6A) and GDH (1.6-fold, Fig. 6F) by thiamin and derivatives is especially 
remarkable in view of the fact that unspecific effects and artifacts are usually inhibiting and rarely able 
to cause enzyme activation. Except for recombinant human PdxK, which might require a regulator and/
or post-translational modifications to respond to physiological concentrations of thiamin and derivatives, 
affinity binding of the brain enzymes to the thiamin and DMHT baits was observed along with efficient 
regulation by the thiamin compounds at 10−5 M (Figs  2A,C and 6C,G,H). This concentration range is 
comparable to steady-state concentrations of total thiamin compounds (10−5 M of total thiamin and its 
phosphate derivatives; thiamin in particular 10−6 M), as determined in cell cultures and different tissues 
including brain6,67–69. It must be also taken into account that both intracellular compartmentalization 
and induced synthesis, such as observed for thiamin triphosphate and adenylated thiamin triphosphate21, 
may significantly increase temporary concentrations of different thiamin compounds in specific com-
partments. In particular, thiamin triphosphate and adenylated thiamin triphosphate have been recently 
shown to serve as alarmones, synthesized in response to amino acid and carbon starvation, although 
their protein targets were not identified21,34. Our data, indicating that GDH is a target of thiamin deriv-
atives (Fig.  6G,H), agrees with earlier observation that thiamin triphosphate was synthesized in vivo 
under amino acid starvation only when cells oxidized pyruvate, but not malate34. It thus appears that 
the thiamin triphosphate-dependent regulation of GDH reaction involving a common intermediate of 
carbon and nitrogen metabolism, 2-oxoglutarate, is essential for metabolic checkpoint.
Overall, our analysis of the thiamin and thiazolium proteomes suggests that biologically relevant 
heterologous complexes, yet not known to be thiamin-dependent, may include proteins regulated by thi-
amin. That is, along with the known thiamin-binding proteins and their immediate interaction partners 
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(Table 2), the eluates from the thiamin and DMHT baits also include proteins of specific metabolic and 
signaling pathways (Table 3) which may respond to thiamin through the interactions within supramo-
lecular structures. The STRING-generated results (Supplementary Fig. S2) provided further support to 
the manual analysis of our data (Tables 2 and 3). Except for the signaling cluster of 14-3-3 proteins, all 
the STRING-identified clusters, such as those related to metabolism, reactive oxygen species and Ca2+ 
signaling, are known to involve ThDP-dependent enzymes22,70,71. Remarkably, thiamin and derivatives 
are also known to participate in biological responses to oxidative stress both as reactive oxygen species 
(ROS) scavengers72,73 and regulators of gene expression74,75. In view of the independent confirmation of 
the majority of the STRING-identified thiamin-dependent clusters, the abundance of 14-3-3 proteins 
and the presence of their different subunits and interacting proteins in both the thiamin and thiazolium 
proteomes (Supplementary Table S1, Fig. S2) favor a direct and biologically significant interaction of 
14-3-3 proteins with thiamin.
The result of our manual search of the data pointed to multiple links between thiamin and the pro-
teins identified in both the thiamin and thiazolium proteomes (Supplementary Table S1). The automatic 
proteome analysis with different bioinformatics tools supported the confidence that co-occurrence of the 
identified proteins upon affinity chromatography is not random. Identification of the protein clusters in 
the eluates from the thiamin or DMHT sorbents (Supplementary Fig. S2) suggests the thiamin depend-
ence of the corresponding pathways. The dependence may be realized through concerted conformational 
changes within supramolecular protein structures upon the thiamin or derivative binding to some of the 
components present in such structures. In particular, multiple components of the redox, ubiquitinylation 
and signaling microcompartments including peroxiredoxins, DJ-1, amyloid-beta precursor and 14-3-3 
proteins are revealed in the thiamin and thiazolium proteomes (Table 3, Supplementary Fig. S2).
Thiamin-dependent regulation of the malate-aspartate shuttle. Figure  9 integrates our data 
into physiological context. The thiamin-dependent regulation of cytosolic MDH1 is directed to inhibit 
the cytosolic malate production (Fig. 6C). This inhibition is especially pronounced at low oxaloacetate 
concentration (Fig.  6D). Concomitant thiamin inhibition of PdxK (Figs  4B,7 and 8, Table  5) may fur-
ther decrease oxaloacetate levels due to the decrease of pyridoxal phosphate level for the aspartate ami-
notransferase reaction. Indeed, a direct transfer of synthesized pyridoxal phosphate between the kinase 
and the aminotransferase has been hypothesized76, which is independently supported by our data. That 
is, a lower abundance of aminotransferase in the thiamin and/or thiazolium proteomes, compared to 
PdxK (Supplementary Table S1) suggests that the interaction of aspartate aminotransferase with the 
two sorbents was mediated through the heterologous complex of the enzyme with pyridoxal kinase, 
detected in both proteomes (Tables 2 and 3). The decrease in cytosolic malate concentration due to the 
thiamin-dependent inhibition of cytosolic MDH1 and PdxK would inhibit the malate transport into 
mitochondria. In other words, high thiamin/ThDP levels in cytoplasm may decrease the efficiency of 
malate-aspartate shuttling of reducing equivalents between mitochondria and cytoplasm (Fig. 9). Worth 
noting, regulation of GDH by thiamin compounds depends on the enzyme saturation with 2-oxoglutarate 
(Fig.  6E,F). This finding links the GDH regulation by thiamin to the malate-aspartate shuttle, as the 
shuttle involves 2-oxoglutarate as an intermediate (Fig. 9). Complexity of allosteric regulation of GDH 
and existence of multiple binding modes for the enzyme nucleotide substrates and regulators64 certainly 
requires future detailed studies of the possible interplay between the thiamin compounds and the known 
regulators of the GDH function.
It must be noted that, due to unfavorable equilibrium, the physiological directions of the reactions 
catalyzed by both GDH and mitochondrial MDH2, are opposite to those used in the standard assays of 
these enzymes in vitro. It is particularly important in this regard that the irreversible processes shifting 
the equilibrium of the physiological reactions of MDH2 (malate oxidation) and GDH (2-oxoglutarate 
production), involve ThDP-dependent pyruvate and 2-oxoglutarate dehydrogenases (Fig.  9). Thus, the 
enzymes revealed to be thiamin-dependent in this work are immediate metabolic neighbors of the 
known ThDP-dependent enzymes of central metabolism. The non-coenzyme action of thiamin on 
MDH1, MDH2, PdxK and GDH is thus coupled to the catalytic action of thiamin as a coenzyme. As a 
result, the concerted regulation of flux distributions through the TCA cycle and associated pathways may 
be achieved, as shown in Fig. 9 and discussed below.
Implications of the protein targets of the non-coenzyme action of thiamin in acetylation 
processes, including the acetylation-dependent metabolic regulation and acetylcholine syn-
thesis. One of the common features revealed with the highest statistical significance in both thiamin 
and thiazolium proteomes is the link of these proteomes to acetylation (Table  4). In the recent years, 
this post-translational modification of proteins has acquired increasing attention in view of its general 
regulatory importance for cellular metabolism77 and fate78. In contrast, the enrichment in the thiamin 
and thiazolium proteomes of the term nucleotide binding is characterized by tenth of orders of magnitude 
lower P-values (Table 4). This indicates that the thiamin and DMHT baits did not fish out the proteins 
which possess the binding sites for nicotinamide and adenine nucleotides, even if partial overlapping of 
such sites in the thiamin-dependent enzymes is possible (Fig. 5). Physiological significance of the highest 
enrichment of the annotation term acetylation in the thiamin and thiazolium proteomes is further sup-
ported by the known metabolic role of the acetylation of MDH1 and MDH279,80, which we revealed to 
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Figure 9. Thiamin-dependent regulation of the tricarboxylic acid (TCA) cycle and associated exchange 
of intermediates between cytoplasm and mitochondria: the malate-aspartate shuttle and the citrate-
dependent transfer of acetyl-CoA. (A)—Distribution of fluxes at a lower thiamin level, when it mainly acts 
as the coenzyme of ThDP-dependent enzymes (Kd ∼ 10−6–10−7 M). (B)—Metabolic switch to increased flux 
through the TCA cycle in the presence of an excess of thiamin and derivatives exerting a non-coenzyme 
action (Kd ∼ 10−5 M). Stimulation and inhibition of the enzymes by thiamin and/or derivatives are shown by 
plus and minus annotations near the corresponding reactions. Effects on MDH 1 and MDH2 refer to low 
saturation of the enzymes with oxaloacetate. Effects on GDH depend on saturation with substrates and the 
present thiamin derivative, as shown in Fig. 6 and described in the text.
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be thiamin targets as well. Remarkably, the intracellular compartmentalization of the cellular acetylating 
agent, acetyl-CoA, should be affected by the discussed above thiamin regulation of the malate fluxes. 
Produced by the ThDP-dependent pyruvate dehydrogenase reaction in mitochondria (Fig. 9), acetyl-CoA 
is transferred to cytoplasm in the form of citrate, which involves the citrate exchange for cytosolic malate 
(Fig. 9). Besides, citrate synthesis in mitochondria from acetyl-CoA requires oxaloacetate. According to 
the results of this work, also the latter is generated in a thiamin-dependent manner (Fig. 9). As shown 
in Fig. 9, the thiamin-induced decrease in formation of cytosolic malate should inhibit the exchange of 
mitochondrial citrate for cytosolic malate (Fig.  9B), increasing the citrate flux through the mitochon-
drial TCA cycle instead. Insofar, the allosteric action of thiamin may underlie the otherwise paradoxical 
effect of thiamin as an inhibitor of the acetylcholine synthesis in synaptosomes, which was mimicked 
by DMHT81. The existence of this regulatory mechanism of thiamin action may also explain facilita-
tion of synaptic transmission, observed upon the thiamin co-release with acetylcholine9–11. That is, the 
neurotransmission-associated changes in intracellular thiamin concentration may be employed to couple 
metabolism and neurotransmission through oscillatory switching of fluxes between the TCA cycle and 
the associated pathway of acetyl-CoA transport from mitochondria to cytoplasm (Fig.  9). Regulatory 
acetylation of proteins may add to the kinetic effects of the coupled action of thiamin compounds as 
coenzyme and allosteric regulators, presented in Fig. 9.
Multiple interactions between metabolic and signaling systems in the thiamin and thiazolium 
proteomes. Metabolic nodes involving the branched-point metabolites pyruvate, 2-oxoglutarate and 
citrate are important for overall metabolic regulation. In particular, recent studies revealed strong net-
working of the 2-oxoglutarate dehydrogenase-catalyzed degradation of 2-oxoglutarate with amino acids 
metabolism and protein homeostasis22. Another study showed that 2-oxoglutarate regulates the activity 
of TOR (Target Of Rapamycin) through the inhibitory binding to ATP synthase82. An interplay between 
thiamin deficiency and TOR activity has also been recently shown83. The thiamin-dependent coupling 
between metabolic network and signal transduction has been further supported by our manual search 
(Tables 2 and 3) and bioinformatics analysis (Supplementary Fig. S2, Fig. 1, Table 4) of the thiamin and 
thiazolium proteomes. The interactome analysis pinpointed possible links between the metabolic and 
regulatory pathways through 14-3-3 proteins, Ca2+ signaling and redox homeostasis (Supplementary 
Fig. S2), supported by published experimental data (Tables 2 and 3). For instance, protein-protein inter-
action between 14-3-3 proteins and glutamine synthetase84, proteins essential for neurotransmission 
and relatively abundant in our proteomes (Supplementary Table S1), could underlie concomitant oxi-
dation of 14-3-3 proteins and glutamine synthetase upon oxidative stress induced by β -amyloid85. On 
the other hand, multiple links between physiological action of thiamin and cellular redox status are 
known. The ThDP-dependent 2-oxo acid dehydrogenase complexes were shown to be physiologically 
relevant sources of not only NADH, but also ROS production86–88. The ThDP-dependent transketolase 
is known to be essential for cellular NAD(P)H reducing potential. Moreover, experimentally confirmed 
functional interaction of the 2-oxo acid dehydrogenase complexes with thioredoxin89 was suggested to 
involve mitochondrial superoxide dismutase 2 (SOD2) and peroxiredoxins70, proteins which are pres-
ent in the thiamin and/or thiazolium proteomes (Supplementary Table S1). The identification of DJ-1 
and amyloid beta precursor protein AP4 in the thiazolium proteome (Supplementary Table S1) may be 
linked to the antioxidant cluster of the thiamin and thiazolium proteomes, supporting the thiamin sig-
nificance in neurodegenerative diseases beyond the NAD(P)H production by ThDP-dependent enzymes. 
The analysis of the thiamin and thiazolium proteomes pursued in the present work provides new level 
of understanding of the molecular mechanisms of thiamin non-coenzyme function, extending the list of 
potential pharmacologically relevant pathways in the vitamin B1-employing therapies.
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